When comparing CSF AT III concentrations in patients with PCNSL with those in patients with secondary CNS lymphoma or lymphoma patients without CNS lesions, or with the non-lymphoma group of patients, a statistically significant difference was seen indicating that CSF AT III concentrations were highest in the group of PCNSL patients (p = 0.006). This evidence concerns the gene SERPINC1 and lymphoma.